FDA Panel Nod For Osteoporosis Drug, PTIE Gets Research Funding, ALDR On Watch

Today's Daily Dose brings you news about Alder Biopharma's after-hours stock movement; Mirati's stock offering; FDA panel recommendation of Amgen/UCB's osteoporosis drug Evenity; and Pain Therapeutics' grant award.

from RTT - Biotech http://bit.ly/2SU5ZXy
via IFTTT